Fluctuation-response design rules for nonequilibrium flows
Physical Review Research · 13.10.2026 · 8 (4)
DOI: 10.1103/g8rc-615y ↗Kurz gefasst
Fachartikel in der Zeitschrift Physical Review Research, online erschienen am 13.10.2026. Verfasst von Ying-Jen Yang und 1 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: John Templeton Foundation, National Institutes of Health, Defense Advanced Research Projects Agency.
Abstract (Originalsprache)
Biomolecular machines operate as stochastic flows on networks. Here, we develop a principled approach to where local transition rates are systematically tuned to achieve global dynamical objectives. Based on the fluctuation-response duality in caliber force theory, our formalism unifies existing nonequilibrium response relations under a single conjugate structure. Topologically, a force-rate Jacobian yields response symmetries that establish a local orthogonal control protocol for network flows. Analytically, it parses covariance to diagnose noise mechanisms, revealing the transition from timing to branching fluctuations in a kinesin motor. With algebraic closure streamlining multiobjective gradient evaluations, this framework provides a unified blueprint for designing stochastic dynamics.
Förderung
- John Templeton Foundation
- National Institutes of Health
- Defense Advanced Research Projects Agency
Zitieren
APA
Yang, Y., & Dill, K. A. (2026). Fluctuation-response design rules for nonequilibrium flows. Physical Review Research, 8(4). https://doi.org/10.1103/g8rc-615y
Vancouver
Yang Y, Dill KA. Fluctuation-response design rules for nonequilibrium flows. Physical Review Research. 2026;8(4). doi:10.1103/g8rc-615y
BibTeX
@article{Yang2026,
author = {Yang, Ying-Jen and Dill, Ken A.},
title = {Fluctuation-response design rules for nonequilibrium flows},
journal = {Physical Review Research},
year = {2026},
volume = {8},
number = {4},
doi = {10.1103/g8rc-615y}
}
EUVIMED